International audienceGeneralized pairwise comparisons have been proposed to permit a comprehensive assessment of several prioritized outcomes between two groups of observations. This procedure estimates Δ, the net chance of a better outcome with treatment than with control by comparing the patients outcomes among all possible pairs taking one patient from the treatment group and one patient from the control group. For time to event outcomes, the standard procedure of generalized pairwise comparisons is analogous to the Gehan’s modification of the Mann-Whitney test which is biased in presence of censored observation and less powerful than Efron’s modification of this test. We adapt Efron’s modification to generalized pairwise comparisons. W...
The conventional approach to comparing a new treatment with a standard therapy is often based on a s...
For composite outcomes whose components can be prioritized on clinical importance, the win ratio, th...
This research sequentially monitors paired survival differences using a new class of non-parametric ...
International audienceGeneralized pairwise comparisons have been proposed to permit a comprehensive ...
The method of generalized pairwise comparisons (GPC) is an extension of the well-known nonparametric...
In survival analysis with competing risks, the treatment effect is typically expressed using cause-s...
The aim of this study is to propose a new pairwise multiple comparison adjustment procedure based on...
In clinical trials, complications in the data structure can arise by design, as when treatment group...
In the analysis of composite endpoints in a clinical trial, time to first event analysis techniques ...
In medical oncology randomized trials, treatment effect is usually assessed on several endpoints, in...
SUMMARY. This research introduces methods for nonparametric testing of weighted integrated survival ...
In clinical studies of survival, additional endpoints on patients may be collected over the course o...
This research introduces methods for nonparametric testing of weighted integrated survival differenc...
Conventional analyses of a composite of multiple time-to-event outcomes use the time to the first ev...
In clinical trials, information about certain time points may be of interest in making decisions abo...
The conventional approach to comparing a new treatment with a standard therapy is often based on a s...
For composite outcomes whose components can be prioritized on clinical importance, the win ratio, th...
This research sequentially monitors paired survival differences using a new class of non-parametric ...
International audienceGeneralized pairwise comparisons have been proposed to permit a comprehensive ...
The method of generalized pairwise comparisons (GPC) is an extension of the well-known nonparametric...
In survival analysis with competing risks, the treatment effect is typically expressed using cause-s...
The aim of this study is to propose a new pairwise multiple comparison adjustment procedure based on...
In clinical trials, complications in the data structure can arise by design, as when treatment group...
In the analysis of composite endpoints in a clinical trial, time to first event analysis techniques ...
In medical oncology randomized trials, treatment effect is usually assessed on several endpoints, in...
SUMMARY. This research introduces methods for nonparametric testing of weighted integrated survival ...
In clinical studies of survival, additional endpoints on patients may be collected over the course o...
This research introduces methods for nonparametric testing of weighted integrated survival differenc...
Conventional analyses of a composite of multiple time-to-event outcomes use the time to the first ev...
In clinical trials, information about certain time points may be of interest in making decisions abo...
The conventional approach to comparing a new treatment with a standard therapy is often based on a s...
For composite outcomes whose components can be prioritized on clinical importance, the win ratio, th...
This research sequentially monitors paired survival differences using a new class of non-parametric ...